Dr. Reddy's Laboratories, Inc. Recall: Divalproex Sodium Extended-Release Tablets, USP, 25
Dr. Reddy's Laboratories, Inc. Recall: Divalproex Sodium Extended-Release Tablets, USP, 25 is one of 9,000 recalls in the RecallGuard dataset. Key details — Recalling firm: Dr. Reddy's Laboratories, Inc.; Product: Divalproex Sodium Extended-Release Tablets, USP, 250 mg a) 100-count bottle (NDC 55111-0533-01), b) 500-co
| Recalling firm | Dr. Reddy's Laboratories, Inc. |
|---|---|
| Product | Divalproex Sodium Extended-Release Tablets, USP, 250 mg a) 100-count bottle (NDC 55111-0533-01), b) 500-count bottle (NDC 55111-0533-05), Rx only, Mfd. By: Dr. Reddy's Laboratories Limited, Bachupally, - 500 090 INDIA |
| Reason for recall | cGMP deviations: Product was exposed above 50% relative humidity levels during packaging operations. |
| Classification | Class II (moderate — may cause temporary or reversible health consequences) |
| Status | Terminated |
| Distribution | Product was distributed to major distributors and retailers who may have further distribute the product throughout the United States. |
| Recall initiated | 20190411 |
| Recall number | D-1133-2019 |
| Category | drug |
| State | NJ |
| Country | United States |
$29/mo
Try RecallGuard →